| |
| |
|
| Insider
Information: |
Clancy Paul J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
138,295 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,757,220 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,295 |
|
|
| Total
Value |
$20,757,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Financial O... |
2019-07-11 |
90,447 |
2017-07-10 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2024-03-28 |
15,785 |
2019-03-29 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
14,701 |
2021-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,536 |
98,550 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,428 |
95,677 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
48,228 |
95,093 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2018-07-10 |
4 |
S |
$131.11 |
$687,148 |
D/D |
(5,241) |
93,309 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-07-11 |
4 |
D |
$124.20 |
$649,566 |
D/D |
(5,230) |
90,447 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2018-02-08 |
4 |
S |
$116.31 |
$707,048 |
D/D |
(6,079) |
89,014 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-02-07 |
4 |
D |
$119.57 |
$715,148 |
D/D |
(5,981) |
87,328 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-02-28 |
4 |
D |
$132.93 |
$143,431 |
D/D |
(1,079) |
86,249 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-03-05 |
4 |
OE |
$58.99 |
$1,695,963 |
D/D |
28,750 |
73,085 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-04-28 |
4 |
OE |
$37.45 |
$608,119 |
D/D |
14,766 |
51,958 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2010-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
9,970 |
51,107 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-09-16 |
4 |
OE |
$41.03 |
$5,556,895 |
D/D |
99,030 |
51,027 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2010-02-24 |
4 |
D |
$55.29 |
$117,325 |
D/D |
(2,122) |
48,985 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2010-06-01 |
4 |
D |
$47.22 |
$59,167 |
D/D |
(1,253) |
47,732 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,521 |
47,618 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-03-05 |
4 |
D |
$71.15 |
$1,841,931 |
D/D |
(25,888) |
47,197 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2009-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,070 |
47,141 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2010-08-01 |
4 |
D |
$55.88 |
$46,660 |
D/D |
(835) |
46,897 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2017-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
46,865 |
46,865 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-02-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
15,690 |
46,821 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-02-23 |
4 |
D |
$66.76 |
$74,704 |
D/D |
(1,119) |
46,499 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2009-06-01 |
4 |
D |
$50.90 |
$63,778 |
D/D |
(1,253) |
45,888 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,690 |
45,863 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-02-12 |
4/A |
AS |
$60.76 |
$58,397 |
D/D |
(958) |
45,863 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2010-09-04 |
4 |
D |
$56.24 |
$62,651 |
D/D |
(1,114) |
45,783 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
